Less than 10 percent of patients prescribed either Xenical (orlistat) or Meridia (sibutramine) are still taking them after one year, and less than 2 percent are still taking them after two years according to a study from the University of Alberta Hospital in Edmonton, Alberta, Canada.
© Copyright 2003-2012 - Larry Hobbs - All Rights Reserved.